{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T16:18:23Z","timestamp":1794845903658,"version":"4.9.1"},"reference-count":68,"publisher":"American Association for Cancer Research (AACR)","issue":"8","license":[{"start":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:00:00Z","timestamp":1723075200000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Emerging evidence supports the important role of the tumor microbiome in oncogenesis, cancer immune phenotype, cancer progression, and treatment outcomes in many malignancies. In this study, we investigated the metastatic melanoma tumor microbiome and its potential roles in association with clinical outcomes, such as survival, in patients with metastatic disease treated with immune checkpoint inhibitors (ICI). Baseline tumor samples were collected from 71 patients with metastatic melanoma before treatment with ICIs. Bulk RNA sequencing (RNA-seq) was conducted on the formalin-fixed, paraffin-embedded and fresh frozen tumor samples. Durable clinical benefit (primary clinical endpoint) following ICIs was defined as overall survival \u226524 months and no change to the primary drug regimen (responders). We processed RNA-seq reads to carefully identify exogenous sequences using the {exotic} tool. The age of the 71 patients with metastatic melanoma ranged from 24 to 83 years, 59% were male, and 55% survived &amp;gt;24 months following the initiation of ICI treatment. Exogenous taxa were identified in the tumor RNA-seq, including bacteria, fungi, and viruses. We found differences in gene expression and microbe abundances in immunotherapy-responsive versus nonresponsive tumors. Responders showed significant enrichment of bacteriophages in the phylum Uroviricota, and nonresponders showed enrichment of several bacteria, including Campylobacter jejuni. These microbes correlated with immune-related gene expression signatures. Finally, we found that models for predicting prolonged survival with immunotherapy using both microbe abundances and gene expression outperformed models using either dataset alone. Our findings warrant further investigation and potentially support therapeutic strategies to modify the tumor microbiome in order to improve treatment outcomes with ICIs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>We analyzed the tumor microbiome and interactions with genes and pathways in metastatic melanoma treated with immunotherapy and identified several microbes associated with immunotherapy response and immune-related gene expression signatures. Machine learning models that combined microbe abundances and gene expression outperformed models using either dataset alone in predicting immunotherapy responses.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-23-0170","type":"journal-article","created":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T04:08:31Z","timestamp":1721189311000},"page":"1978-1990","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The Tumor Microbiome as a Predictor of Outcomes in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibitors"],"prefix":"10.1158","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3374-4909","authenticated-orcid":false,"given":"Caroline E.","family":"Dravillas","sequence":"first","affiliation":[{"name":"Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio. 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3092-1197","authenticated-orcid":false,"suffix":"IV","given":"Samuel S.","family":"Coleman","sequence":"additional","affiliation":[{"name":"Department of Oncological Science, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah. 2"},{"name":"Department of Biomedical Informatics, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah. 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1210-4491","authenticated-orcid":false,"given":"Rebecca","family":"Hoyd","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio. 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3231-1666","authenticated-orcid":false,"given":"Griffin","family":"Caryotakis","sequence":"additional","affiliation":[{"name":"Department of Oncological Science, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah. 2"},{"name":"Department of Biomedical Informatics, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah. 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5821-7873","authenticated-orcid":false,"given":"Louis","family":"Denko","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio. 1"},{"name":"Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio. 4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3656-2470","authenticated-orcid":false,"given":"Carlos H.F.","family":"Chan","sequence":"additional","affiliation":[{"name":"Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa. 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6560-1056","authenticated-orcid":false,"given":"Michelle L.","family":"Churchman","sequence":"additional","affiliation":[{"name":"Aster Insights, Hudson, Florida. 6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6875-734X","authenticated-orcid":false,"given":"Nicholas","family":"Denko","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio. 7"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7295-1882","authenticated-orcid":false,"given":"Rebecca D.","family":"Dodd","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Iowa, Iowa City, Iowa. 8"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6387-5419","authenticated-orcid":false,"given":"Islam","family":"Eljilany","sequence":"additional","affiliation":[{"name":"Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. 9"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0292-6168","authenticated-orcid":false,"given":"Sheetal","family":"Hardikar","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah. 10"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2649-1154","authenticated-orcid":false,"given":"Marium","family":"Husain","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio. 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4448-9755","authenticated-orcid":false,"given":"Alexandra P.","family":"Ikeguchi","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, Stephenson Cancer Center of University of Oklahoma, Oklahoma City, Oklahoma. 11"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6689-4671","authenticated-orcid":false,"given":"Ning","family":"Jin","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio. 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3264-8392","authenticated-orcid":false,"given":"Qin","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics, The Ohio State University, Columbus, Ohio. 12"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8174-1713","authenticated-orcid":false,"given":"Martin D.","family":"McCarter","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Colorado School of Medicine, Aurora, Colorado. 13"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3688-4683","authenticated-orcid":false,"given":"Afaf E.G.","family":"Osman","sequence":"additional","affiliation":[{"name":"Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, University of Utah, Salt Lake City, Utah. 14"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4579-0141","authenticated-orcid":false,"given":"Lary A.","family":"Robinson","sequence":"additional","affiliation":[{"name":"Department of Thoracic Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. 15"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3991-0696","authenticated-orcid":false,"given":"Eric A.","family":"Singer","sequence":"additional","affiliation":[{"name":"Division of Urologic Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio. 16"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2565-6124","authenticated-orcid":false,"given":"Gabriel","family":"Tinoco","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio. 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7641-059X","authenticated-orcid":false,"given":"Cornelia M.","family":"Ulrich","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah. 10"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9480-2626","authenticated-orcid":false,"given":"Yousef","family":"Zakharia","sequence":"additional","affiliation":[{"name":"Division of Oncology, Hematology and Blood and Marrow Transplantation, University of Iowa, Holden Comprehensive Cancer Center, Iowa City, Iowa. 17"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2314-6435","authenticated-orcid":false,"given":"Daniel","family":"Spakowicz","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio. 1"},{"name":"Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio. 4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3193-9702","authenticated-orcid":false,"given":"Ahmad A.","family":"Tarhini","sequence":"additional","affiliation":[{"name":"Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. 9"},{"name":"Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. 18"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2955-8369","authenticated-orcid":false,"given":"Aik Choon","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Oncological Science, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah. 2"},{"name":"Department of Biomedical Informatics, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah. 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the exORIEN Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2024,8,8]]},"reference":[{"key":"2025032818092906300_bib1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined nivolumab and ipilimumab or monotherapy in untreated melanoma","volume":"373","author":"Larkin","year":"2015","journal-title":"N Engl J Med"},{"key":"2025032818092906300_bib2","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1056\/NEJMc1713444","article-title":"Tumor mutational burden and response rate to PD-1 inhibition","volume":"377","author":"Yarchoan","year":"2017","journal-title":"N Engl J Med"},{"key":"2025032818092906300_bib3","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1126\/science.aaf1490","article-title":"Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade","volume":"351","author":"McGranahan","year":"2016","journal-title":"Science"},{"key":"2025032818092906300_bib4","doi-asserted-by":"crossref","first-page":"pkaa115","DOI":"10.1093\/jncics\/pkaa115","article-title":"Predicting toxicity and response to pembrolizumab through germline genomic HLA class 1 analysis","volume":"5","author":"Iafolla","year":"2020","journal-title":"JNCI Cancer Spectr"},{"key":"2025032818092906300_bib5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40425-015-0070-4","article-title":"Peripheral T cell receptor diversity is associated with clinical outcomes following ipilimumab treatment in metastatic melanoma","volume":"3","author":"Postow","year":"2015","journal-title":"J Immunother Cancer"},{"key":"2025032818092906300_bib6","doi-asserted-by":"crossref","first-page":"eaaf8399","DOI":"10.1126\/science.aaf8399","article-title":"Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy","volume":"355","author":"Davoli","year":"2017","journal-title":"Science"},{"key":"2025032818092906300_bib7","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.immuni.2021.01.011","article-title":"Germline genetic contribution to the immune landscape of cancer","volume":"54","author":"Sayaman","year":"2021","journal-title":"Immunity"},{"key":"2025032818092906300_bib8","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1182\/blood-2017-11-742577","article-title":"The MYC oncogene is a global regulator of the immune response","volume":"131","author":"Casey","year":"2018","journal-title":"Blood"},{"key":"2025032818092906300_bib9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature14404","article-title":"Melanoma-intrinsic \u03b2-catenin signalling prevents anti-tumour immunity","volume":"523","author":"Spranger","year":"2015","journal-title":"Nature"},{"key":"2025032818092906300_bib10","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1158\/1078-0432.CCR-18-1942","article-title":"WNT\/\u03b2-catenin pathway activation correlates with immune exclusion across human cancers","volume":"25","author":"Luke","year":"2019","journal-title":"Clin Cancer Res"},{"key":"2025032818092906300_bib11","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.immuni.2017.11.016","article-title":"Oncogenic RAS signaling promotes tumor immunoresistance by stabilizing PD-L1 mRNA","volume":"47","author":"Coelho","year":"2017","journal-title":"Immunity"},{"key":"2025032818092906300_bib12","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1172\/JCI91190","article-title":"IFN-\u03b3-related mRNA profile predicts clinical response to PD-1 blockade","volume":"127","author":"Ayers","year":"2017","journal-title":"J Clin Invest"},{"key":"2025032818092906300_bib13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ajpath.2011.03.007","article-title":"Unique ectopic lymph node-like structures present in human primary colorectal carcinoma are identified by immune gene array profiling","volume":"179","author":"Coppola","year":"2011","journal-title":"Am J Pathol"},{"key":"2025032818092906300_bib14","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/srep00765","article-title":"12-Chemokine gene signature identifies lymph node-like structures in melanoma: potential for selection for immunotherapy?","volume":"2","author":"Messina","year":"2012","journal-title":"Sci Rep"},{"key":"2025032818092906300_bib15","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/s41591-021-01331-8","article-title":"Evolution of delayed resistance to immunotherapy in a melanoma responder","volume":"27","author":"Liu","year":"2021","journal-title":"Nat Med"},{"key":"2025032818092906300_bib16","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/S0140-6736(16)00587-0","article-title":"Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial","volume":"387","author":"Fehrenbacher","year":"2016","journal-title":"Lancet"},{"key":"2025032818092906300_bib17","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1182\/bloodadvances.2016000786","article-title":"Mutation load and an effector T-cell gene signature may distinguish immunologically distinct and clinically relevant lymphoma subsets","volume":"1","author":"Bolen","year":"2017","journal-title":"Blood Adv"},{"key":"2025032818092906300_bib18","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2021.01.002","article-title":"Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition","volume":"184","author":"Litchfield","year":"2021","journal-title":"Cell"},{"key":"2025032818092906300_bib19","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1126\/science.aay9189","article-title":"The human tumor microbiome is composed of tumor type\u2013specific intracellular bacteria","volume":"368","author":"Nejman","year":"2020","journal-title":"Science"},{"key":"2025032818092906300_bib20","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1038\/s41467-022-30512-3","article-title":"Predicting cancer prognosis and drug response from the tumor microbiome","volume":"13","author":"Hermida","year":"2022","journal-title":"Nat Commun"},{"key":"2025032818092906300_bib21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/cpt.1051","article-title":"Patient enrichment for precision-based cancer clinical trials: using prospective cohort surveillance as an approach to improve clinical trials","volume":"104","author":"Dalton","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"2025032818092906300_bib22","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/S1470-2045(16)30366-7","article-title":"Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial","volume":"17","author":"Hodi","year":"2016","journal-title":"Lancet Oncol"},{"key":"2025032818092906300_bib23","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1001\/jamaoncol.2023.1891","article-title":"Association between duration of immunotherapy and overall survival in advanced non\u2013small cell lung cancer","volume":"9","author":"Sun","year":"2023","journal-title":"JAMA Oncol"},{"key":"2025032818092906300_bib24","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1093\/annonc\/mdt291","article-title":"Efficacy and safety of ipilimumab in metastatic melanoma patients surviving more than 2 years following treatment in a phase III trial (MDX010-20)","volume":"24","author":"McDermott","year":"2013","journal-title":"Ann Oncol"},{"key":"2025032818092906300_bib25","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1158\/2767-9764.CRC-22-0435","article-title":"Exogenous sequences in tumors and immune cells (exotic): a tool for estimating the microbe abundances in tumor RNA-seq data","volume":"3","author":"Hoyd","year":"2023","journal-title":"Cancer Res Commun"},{"key":"2025032818092906300_bib26","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"2025032818092906300_bib27","article-title":"vegan: community ecology package [internet]","author":"Oksanen","year":"2018"},{"key":"2025032818092906300_bib28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/mc.23442","article-title":"Systematic evaluation of the predictive gene expression signatures of immune checkpoint inhibitors in metastatic melanoma","volume":"62","author":"Coleman","year":"2023","journal-title":"Mol Carcinog"},{"key":"2025032818092906300_bib29","doi-asserted-by":"crossref","first-page":"e004310","DOI":"10.1136\/jitc-2021-004310","article-title":"Improved prognosis and evidence of enhanced immunogenicity in tumor and circulation of high-risk melanoma patients with unknown primary","volume":"10","author":"Tarhini","year":"2022","journal-title":"J Immunother Cancer"},{"key":"2025032818092906300_bib30","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"2025032818092906300_bib31","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1093\/bioinformatics\/btab244","article-title":"TIMEx: tumor-immune microenvironment deconvolution web-portal for bulk transcriptomics using pan-cancer scRNA-seq signatures","volume":"37","author":"Xie","year":"2021","journal-title":"Bioinformatics"},{"key":"2025032818092906300_bib32","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ccell.2019.01.003","article-title":"Distinct immune cell populations define response to anti-PD-1 monotherapy and anti-PD-1\/anti-CTLA-4 combined therapy","volume":"35","author":"Gide","year":"2019","journal-title":"Cancer Cell"},{"key":"2025032818092906300_bib33","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.cell.2017.09.028","article-title":"Tumor and microenvironment evolution during immunotherapy with nivolumab","volume":"171","author":"Riaz","year":"2017","journal-title":"Cell"},{"key":"2025032818092906300_bib34","doi-asserted-by":"crossref","first-page":"e1231291","DOI":"10.1080\/2162402X.2016.1231291","article-title":"Expression profiles of immune-related genes are associated with neoadjuvant ipilimumab clinical benefit","volume":"6","author":"Tarhini","year":"2016","journal-title":"Oncoimmunology"},{"key":"2025032818092906300_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2019.10.012","article-title":"Gene signatures of tumor inflammation and epithelial-to-mesenchymal transition (EMT) predict responses to immune checkpoint blockade in lung cancer with high accuracy","volume":"139","author":"Thompson","year":"2020","journal-title":"Lung Cancer"},{"key":"2025032818092906300_bib36","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nature13954","article-title":"PD-1 blockade induces responses by inhibiting adaptive immune resistance","volume":"515","author":"Tumeh","year":"2014","journal-title":"Nature"},{"key":"2025032818092906300_bib37","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s13059-016-1092-z","article-title":"Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures","volume":"17","author":"\u015eenbabao\u011flu","year":"2016","journal-title":"Genome Biol"},{"key":"2025032818092906300_bib38","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/imr.12518","article-title":"TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy","volume":"276","author":"Dougall","year":"2017","journal-title":"Immunol Rev"},{"key":"2025032818092906300_bib39","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1158\/1078-0432.CCR-21-3329","article-title":"Transcriptomic determinants of response to pembrolizumab monotherapy across solid tumor types","volume":"28","author":"Cristescu","year":"2022","journal-title":"Clin Cancer Res"},{"key":"2025032818092906300_bib40","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41591-019-0357-y","article-title":"A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma","volume":"25","author":"Huang","year":"2019","journal-title":"Nat Med"},{"key":"2025032818092906300_bib41","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/s41467-017-01018-0","article-title":"Genomic landscape associated with potential response to anti-CTLA-4 treatment in cancers","volume":"8","author":"Ock","year":"2017","journal-title":"Nat Commun"},{"key":"2025032818092906300_bib42","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.1038\/s41467-020-18546-x","article-title":"A gene expression signature of TREM2hi macrophages and \u03b3\u03b4 T cells predicts immunotherapy response","volume":"11","author":"Xiong","year":"2020","journal-title":"Nat Commun"},{"key":"2025032818092906300_bib43","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1126\/science.aao3290","article-title":"The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients","volume":"359","author":"Matson","year":"2018","journal-title":"Science"},{"key":"2025032818092906300_bib44","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1126\/science.aan4236","article-title":"Gut microbiome modulates response to anti\u2013PD-1 immunotherapy in melanoma patients","volume":"359","author":"Gopalakrishnan","year":"2018","journal-title":"Science"},{"key":"2025032818092906300_bib45","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.aan3706","article-title":"Gut microbiome influences efficacy of PD-1\u2013based immunotherapy against epithelial tumors","volume":"359","author":"Routy","year":"2018","journal-title":"Science"},{"key":"2025032818092906300_bib46","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1126\/science.abf3363","article-title":"Fecal microbiota transplant overcomes resistance to anti\u2013PD-1 therapy in melanoma patients","volume":"371","author":"Davar","year":"2021","journal-title":"Science"},{"key":"2025032818092906300_bib47","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1126\/science.abb5920","article-title":"Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients","volume":"371","author":"Baruch","year":"2021","journal-title":"Science"},{"key":"2025032818092906300_bib48","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41586-020-2095-1","article-title":"Microbiome analyses of blood and tissues suggest cancer diagnostic approach","volume":"579","author":"Poore","year":"2020","journal-title":"Nature"},{"key":"2025032818092906300_bib49","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1126\/science.aah5043","article-title":"Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine","volume":"357","author":"Geller","year":"2017","journal-title":"Science"},{"key":"2025032818092906300_bib50","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.ccell.2021.08.006","article-title":"Microbiome and cancer","volume":"39","author":"Cullin","year":"2021","journal-title":"Cancer Cell"},{"key":"2025032818092906300_bib51","volume-title":"A review of human carcinogens","author":"Centre International de Recherche sur le Cancer","year":"2012"},{"key":"2025032818092906300_bib52","doi-asserted-by":"crossref","first-page":"9","DOI":"10.21315\/mjms2020.27.4.2","article-title":"The mechanism of Bacteroides fragilis toxin contributes to colon cancer formation","volume":"27","author":"Cheng","year":"2020","journal-title":"Malays J Med Sci"},{"key":"2025032818092906300_bib53","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.chom.2018.01.007","article-title":"Bacteroides fragilis toxin coordinates a pro-carcinogenic inflammatory cascade via targeting of colonic epithelial cells","volume":"23","author":"Chung","year":"2018","journal-title":"Cell Host Microbe"},{"key":"2025032818092906300_bib54","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41586-020-2080-8","article-title":"Mutational signature in colorectal cancer caused by genotoxic pks+E. coli","volume":"580","author":"Pleguezuelos-Manzano","year":"2020","journal-title":"Nature"},{"key":"2025032818092906300_bib55","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.3748\/wjg.v20.i11.2751","article-title":"Helicobacter pylori infection in gastric mucosa-associated lymphoid tissue lymphoma","volume":"20","author":"Park","year":"2014","journal-title":"World J Gastroenterol"},{"key":"2025032818092906300_bib56","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1038\/s41388-020-1304-6","article-title":"Spermine oxidase mediates Helicobacter pylori-induced gastric inflammation, DNA damage, and carcinogenic signaling","volume":"39","author":"Sierra","year":"2020","journal-title":"Oncogene"},{"key":"2025032818092906300_bib57","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/s41586-019-1608-2","article-title":"The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL","volume":"574","author":"Aykut","year":"2019","journal-title":"Nature"},{"key":"2025032818092906300_bib58","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1126\/science.aax0701","article-title":"Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage","volume":"369","author":"Fluckiger","year":"2020","journal-title":"Science"},{"key":"2025032818092906300_bib59","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrmicro1718","article-title":"Campylobacter jejuni: molecular biology and pathogenesis","volume":"5","author":"Young","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"2025032818092906300_bib60","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s41586-021-03368-8","article-title":"Identification of bacteria-derived HLA-bound peptides in melanoma","volume":"592","author":"Kalaora","year":"2021","journal-title":"Nature"},{"key":"2025032818092906300_bib61","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ccell.2021.11.012","article-title":"Multiomic profiling of checkpoint inhibitor-treated melanoma: identifying predictors of response and resistance, and markers of biological discordance","volume":"40","author":"Newell","year":"2022","journal-title":"Cancer Cell"},{"key":"2025032818092906300_bib62","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s10549-013-2622-y","article-title":"A meta-analysis of gene expression-based biomarkers predicting outcome after tamoxifen treatment in breast cancer","volume":"140","author":"Mih\u00e1ly","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"2025032818092906300_bib63","doi-asserted-by":"crossref","first-page":"5928","DOI":"10.1111\/jcmm.13863","article-title":"A four-gene-based prognostic model predicts overall survival in patients with hepatocellular carcinoma","volume":"22","author":"Long","year":"2018","journal-title":"J Cell Mol Med"},{"key":"2025032818092906300_bib64","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1126\/science.aad1329","article-title":"Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota","volume":"350","author":"V\u00e9tizou","year":"2015","journal-title":"Science"},{"key":"2025032818092906300_bib65","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1126\/science.abc3421","article-title":"Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy","volume":"369","author":"Mager","year":"2020","journal-title":"Science"},{"key":"2025032818092906300_bib66","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.cell.2023.03.011","article-title":"Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment","volume":"186","author":"Bender","year":"2023","journal-title":"Cell"},{"key":"2025032818092906300_bib67","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.21.02229","article-title":"Long-term outcomes with nivolumab plus ipilimumab or nivolumab alone versus ipilimumab in patients with advanced melanoma","volume":"40","author":"Wolchok","year":"2022","journal-title":"J Clin Oncol"},{"key":"2025032818092906300_bib68","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.ccell.2022.09.009","article-title":"Tumor microbiome links cellular programs and immunity in pancreatic cancer","volume":"40","author":"Ghaddar","year":"2022","journal-title":"Cancer Cell"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-23-0170\/3475274\/crc-23-0170.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/4\/8\/1978\/3504963\/crc-23-0170.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/4\/8\/1978\/3504963\/crc-23-0170.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T19:22:27Z","timestamp":1743189747000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/4\/8\/1978\/746919\/The-Tumor-Microbiome-as-a-Predictor-of-Outcomes-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,1]]},"references-count":68,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-23-0170","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.26519596","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27180183","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27180171","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26519626.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28688851","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26519599.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26519629.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26519614","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27180159","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26519626","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26519623.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28688839","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26519620.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27180174","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26519620","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27180186","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26519587","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27180162","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26519599","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26519632","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26519587.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28688830","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28688842","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28688854","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26519605","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26519617","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26519629","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26519623","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27180165","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26519611","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27180177","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26519590","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26519632.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28688833","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28688845","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28688857","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26519593.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26519590.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26519608","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26519596.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26519614.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27180168","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26519602","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26519608.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26519617.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26519611.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26519593","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.27180180","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26519602.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.26519605.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28688836","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28688848","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.7393399","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.c.7393399.v1","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,1]]}}}